Otros idiomas GemVax&KAEL Co.,Ltd.

Acciones

A082270

KR7082270000

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 11/06/2024			Varia. Cinco días.	Varia. 1 de enero.
10.930 ^KRW	-0,64 %		-6,58 %	-17,70 %

2022	GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) anuncia una recompra de acciones por 150.000 acciones.	CI
2022	GemVax&KAEL Co.,Ltd autoriza un plan de recompra.	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Gemvaxlink Co., Ltd. announced that it has received KRW 39.0999772 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd	02/05
GemVax&KAEL Co.,Ltd. announced that it has received KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	25/03
GemVax&KAEL Co.,Ltd. announced that it expects to receive KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	21/03
Gemvaxlink Co., Ltd. announced that it has received KRW 29.099978456 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd and other investors	18/03
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on June 14, 2022.	31/08/22
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 150,000 shares.	14/06/22
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	14/06/22
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on April 13, 2022.	13/06/22
GemVax&KAEL Co.,Ltd's Equity Buyback announced on April 13, 2022, has closed with 300,000 shares, representing 0.76% for KRW 4,333.75 million.	10/06/22
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 300,000 shares.	13/04/22
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	13/04/22
GemVax&KAEL Co.,Ltd(KOSDAQ:A082270) added to S&P Global BMI Index	20/09/21
GemVax&KAEL Co.,Ltd acquired additional 12.9% stake in Gemvaxlink Co., Ltd. for KRW 18 billion.	19/08/21
GemVax&KAEL Co.,Ltd acquired additional 12.99% stake in Gemvaxzio Co., Ltd. for KRW 18.02 billion.	19/08/21
Gemvax & Kael : highly promising Phase II Alzheimer's disease clinical trial results targeting telomerase published in prestigious Alzheimer's Research & Therapy' journal	30/03/21
GemVax's Highly Promising Phase II Alzheimer's Disease Clinical Trial Results Targeting Telomerase Published in Alzheimer's Research & Therapy' Journal	30/03/21
GemVax&KAEL Co.,Ltd(KOSDAQ:A082270) dropped from S&P Global BMI Index	22/03/21
GemVax & KAEL Announces the Decision to Apply for an Expanded Access IND for Its Lead Candidate GV1001 to Include Additional Investigational Groups in Alzheimer's	06/10/20
Gemvaxzio Co., Ltd. announced that it has received KRW 3.49999944 billion in funding from GemVax&KAEL Co.,Ltd	18/06/20
Gemvaxzio Co., Ltd. announced that it expects to receive KRW 3.49999944 billion in funding from GemVax&KAEL Co.,Ltd	10/06/20

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas GemVax&KAEL Co.,Ltd.

Acciones

A082270

KR7082270000

Otros idiomas

Filtros